NO20011173L - Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer - Google Patents

Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Info

Publication number
NO20011173L
NO20011173L NO20011173A NO20011173A NO20011173L NO 20011173 L NO20011173 L NO 20011173L NO 20011173 A NO20011173 A NO 20011173A NO 20011173 A NO20011173 A NO 20011173A NO 20011173 L NO20011173 L NO 20011173L
Authority
NO
Norway
Prior art keywords
fats
preparations
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
NO20011173A
Other languages
English (en)
Other versions
NO20011173D0 (no
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NO20011173D0 publication Critical patent/NO20011173D0/no
Publication of NO20011173L publication Critical patent/NO20011173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelse tilveiebringer fremgangsmåter for å øke fett- absorpsjon fra tarmkanalen ved å øke mengden lysofosfatidyl- cholin i tarmkanalen. Ethvert middel som øker intestinal lysofosfatidylcholin kan anvendes, foretrukket dem som administreres oralt til individet.
NO20011173A 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer NO20011173L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
NO20011173D0 NO20011173D0 (no) 2001-03-07
NO20011173L true NO20011173L (no) 2001-05-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011173A NO20011173L (no) 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Country Status (13)

Country Link
US (1) US6426069B1 (no)
EP (1) EP1119360B1 (no)
JP (1) JP4700193B2 (no)
CN (1) CN1321089A (no)
AT (1) ATE347371T1 (no)
AU (1) AU771901B2 (no)
CA (1) CA2343116C (no)
DE (1) DE69934325T2 (no)
IL (2) IL141801A0 (no)
NO (1) NO20011173L (no)
NZ (1) NZ510536A (no)
WO (1) WO2000013689A1 (no)
ZA (1) ZA200102268B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2788500C (en) * 2001-10-11 2017-08-01 Biomolecular Products, Inc. Modifications of solid 3-sn-phosphoglycerides
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
PT1594544T (pt) * 2003-01-31 2016-07-14 Los Angeles Childrens Hospital Composições orais de fenretinida tendo biodisponibilidade aumentada e métodos de utilização das mesmas
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
JP5768294B2 (ja) * 2010-10-22 2015-08-26 学校法人福岡大学 胃上皮性腫瘍（腺腫・胃癌）の診断に有用な白色不透明物質を応用した診断能改善用組成物
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
BR112021002490A2 (pt) * 2018-09-21 2021-10-19 Société des Produits Nestlé S.A. Composições e métodos para o tratamento de insuficiência pancreática exócrina (ipe)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
AU666293B2 (en) * 1990-08-13 1996-02-08 David W. Yesair Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
CA2222161C (en) * 1995-06-06 2002-02-05 Biomolecular Products, Inc. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
US20030175277A1 (en) 1996-09-11 2003-09-18 Elizabeth Shanahan-Prendergast Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
CA2343116A1 (en) 2000-03-16
DE69934325D1 (de) 2007-01-18
NZ510536A (en) 2003-07-25
EP1119360A4 (en) 2003-06-04
JP2002524417A (ja) 2002-08-06
US6426069B1 (en) 2002-07-30
EP1119360B1 (en) 2006-12-06
ZA200102268B (en) 2001-09-19
IL141801A0 (en) 2002-03-10
CN1321089A (zh) 2001-11-07
JP4700193B2 (ja) 2011-06-15
DE69934325T2 (de) 2007-07-05
CA2343116C (en) 2008-11-18
AU5705299A (en) 2000-03-27
AU771901B2 (en) 2004-04-08
ATE347371T1 (de) 2006-12-15
NO20011173D0 (no) 2001-03-07
EP1119360A1 (en) 2001-08-01
WO2000013689A1 (en) 2000-03-16
IL141801A (en) 2009-02-11

Similar Documents

Publication Publication Date Title
ZA966798B (en) Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions.
IS5566A (is) Afurðir úr karótínsskyldum fituefnahlutum sæbjúgna og aðferðir við notkun þeirra
NO20011173L (no) Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer
EP1435946B8 (en) Linked biaryl compounds
IS4720A (is) Aðferð og lyfjablanda til að stýra styrk lípíða
IT1277511B1 (it) Metodo per generare visualizzazioni m-mode anatomiche
DE60136490D1 (de) Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
HUP0101378A3 (en) Method for enhancing presentation of text
AU1123800A (en) Method and apparatus for modeling and executing deferred award instrument plan
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
FR2833100B1 (fr) Procede de reconstitution d'une image d'un organe
NO953043D0 (no) Fremgangsmåte for syntetisere acetotriglyceridfett
DK0785773T3 (da) Etherlipidliposomer og deres terapeutiske anvendelse
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
MX9606503A (es) Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno.
NO20024722D0 (no) Stivelses-subtyper og lipid metabolisme
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
DE69622907D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Silicon-Zusammensetzungen
DE69630666D1 (de) Wirkstoff für verbesserten fettstoffwechsel
NO963497L (no) Fibrin-spesifikt antistoff for anvendelse som et antitrombotisk middel
NO975504D0 (no) Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
AU6084499A (en) Self-emulsifying water-in-oil emulsion bases
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
FR2753200B1 (fr) Procede d'extraction de lipides provenant de la lecithine de soja, extrait lipidique obtenu et compositions dermato-cosmetiques le contenant
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application